The “insulin pen”: Comparison with multiple injection treatment with syringe
作者： K Dahl-Jorgensen , Kf Hanssen , R Mosand , L Sandvik
关键词:
摘要: A new insulin “fountain-pen” injection device (NovoPenTM) was tested in 10 insulin-dependent diabetic patients, aged 21–34 years, who had used multiple therapy with syringe-injections for more than one year previously. The patients strict pre-study blood glucose control; HbA1 8.8% ± 1.9. They NovoPen 6–9 months (mean 8 months). increased slightly during pen treatment to 9.3% 1.8 (p < 0.01), probably due insufficient delivery. All but patient experienced technical problems the devices. all wanted continue using it, because of simplicity injections and daily life flexibility. Since have no direct control over amount injected, caution is needed when introducing injections.
sci-hub.se 参考文章(11)
J. A. Galloway, F. Bruce Peck, S. Edwin Fineberg, C. Thomas Spradlin, J. H. Marsden, D. Allemenos, J. Ingulli-Fattic, The U.S. "new patient" and "transfer" studies. Diabetes Care. ,vol. 5, pp. 135- 139 ,(1982) , 10.2337/DIACARE.5.2.S135
A. S. Berger, N. Saurbrey, C. Kuhl, J. Villumsen, Clinical Experience with a New Device that Will Simplify Insulin Injections Diabetes Care. ,vol. 8, pp. 73- 76 ,(1985) , 10.2337/DIACARE.8.1.73
F. W. Kemmer, G. Sonnenberg, H. J. Cuppers, M. Berger, Absorption Kinetics of Semisynthetic Human Insulin and Biosynthetic (recombinant DNA)Human Insulin Diabetes Care. ,vol. 5, pp. 23- 28 ,(1982) , 10.2337/DIACARE.5.2.S23
J. S. Skyler, D. E. Seigler, M. L. Reeves, Optimizing Pumped Insulin Delivery Diabetes Care. ,vol. 5, pp. 135- 139 ,(1982) , 10.2337/DIACARE.5.2.135
G. E. Sonnenberg, E. Chantelau, S. Sundermann, C. Hauff, M. Berger, Human and porcine regular insulins are equally effective in subcutaneous replacement therapy. Results of a double-blind crossover study in type I diabetic patients with continuous subcutaneous insulin infusion. Diabetes. ,vol. 31, pp. 600- 602 ,(1982) , 10.2337/DIAB.31.7.600
G.E. Sonnenberg, M. Berger, Human Insulin: Much Ado About One Amino Acid? Diabetologia. ,vol. 25, pp. 457- 459 ,(1983) , 10.1007/BF00284450
Werner K. Waldhäusl, Paul R. Bratusch-Marrain, Heinrich Vierhapper, Peter Nowotny, Insulin pharmacokinetics following continuous infusion and bolus injection of regular porcine and human insulin in healthy man Metabolism. ,vol. 32, pp. 478- 486 ,(1983) , 10.1016/0026-0495(83)90010-0
K Dahl-Jorgensen, O Brinchmann-Hansen, K F Hanssen, L Sandvik, O Aagenaes, Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study BMJ. ,vol. 290, pp. 811- 815 ,(1985) , 10.1136/BMJ.290.6471.811
A. Schiffrin, M. M. Belmonte, Comparison Between Continuous Subcutaneous Insulin Infusion and Multiple Injections of Insulin: A One-Year Prospective Study Diabetes. ,vol. 31, pp. 255- 264 ,(1982) , 10.2337/DIAB.31.3.255
AdrianJ.L Clark, Graham Knight, PhilipG Wiles, Harry Keen, JohnD Ward, JoanM Cauldwell, RodneyO Adeniyi-Jones, JamesM Leiper, RichardH Jones, AngusC Maccuish, PeterJ Watkins, Alan Glynne, JanetB Scotton, BIOSYNTHETIC HUMAN INSULIN IN THE TREATMENT OF DIABETES: A Double-blind Crossover Trial in Established Diabetic Patients The Lancet. ,vol. 320, pp. 354- 357 ,(1982) , 10.1016/S0140-6736(82)90548-7